Skip to search formSkip to main contentSkip to account menu

Digestive System Neuroendocrine Tumor

Known as: Digestive System NET, Gastrointestinal Neuroendocrine Tumor, Gastrointestinal System Neuroendocrine Tumor 
A well-differentiated neuroendocrine tumor arising from the digestive system. It is characterized by the presence of cells with features similar to… 
National Institutes of Health

Related topics

Related topics

5 relations
Endocrine systemEpithelial CellsEpitheliumGastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning
The Ki-67 index is an established prognostic factor in gastrointestinal neuroendocrine tumors (GI-NETs) and defines tumor grade… 
Review
2017
Review
2017
Peripancreatic paraganglioma mimics pancreatic/gastrointestinal neuroendocrine tumor on fine needle aspiration: Report of two cases and review of the literature
Cytologic diagnosis of extra‐adrenal paraganglioma presenting as a peripancreatic mass is challenging with a high error rate due… 
2016
2016
Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
BACKGROUND Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) are relatively rare tumors, not equally distributed in the… 
Review
2016
Review
2016
Successful Hepatectomy Using Venovenous Bypass in a Patient With Carcinoid Heart Disease and Severe Tricuspid Regurgitation.
GASTROINTESTINAL NEUROENDOCRINE tumor (GINET) is an uncommon, slow-growing tumor arising from neuroendocrine cells. Its incidence… 
2014
2014
Incidence of Additional Primary Malignancies in Patients with Pancreatic and Gastrointestinal Neuroendocrine Tumors
BackgroundThe incidence of secondary malignancies is increased in patients with malignant and premalignant conditions. Although… 
Review
2013
Review
2013
Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.
Well-differentiated neuroendocrine tumors (NETs) are a group of heterogeneous rare tumors. They are often slow-growing and… 
Highly Cited
2007
Highly Cited
2007
Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression‐free survival among patients with low‐grade neuroendocrine tumors
Vascular endothelial growth factor (VEGF) is a critical proangiogenic factor in solid tumors. However, its expression and role in… 
Highly Cited
2006
Highly Cited
2006
Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Treatment options of advanced neuroendocrine tumors (NETs) are unsatisfactory. Hence, innovative therapeutic approaches are… 
2005
2005
The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
BACKGROUND/AIMS Expression of CD44 and its isoforms has been demonstrated to be a prognostic marker in many neoplasms… 
1997
1997
Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
There are six major steps in the management of patients with neuroendocrine tumors (NETs) (carcinoids and pancreatic endocrine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)